CRESEMBA
NDC 0469-0520, isavuconazonium sulfate, capsule, from Astellas Pharma US, Inc..
- Product NDC
- 0469-0520
- Status
- Listed
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207500
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0469-0520 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ISAVUCONAZONIUM SULFATE100 mg/1
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 3A4 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0469-0520-02 | 00469052002 | 2 BLISTER PACK in 1 CARTON (0469-0520-02) / 7 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8f7f73b8-586a-4df0-935f-fecd4696c16cNADAC price for package 00469052002
GET /v1/drugs/nadac/00469052002
Use it
Look up 0469-0520 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0469-0520 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0469-0520. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.